Publication: Reuters
Abstract
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in alignment with FDA initiatives to reduce animal testing. Read this Reuters article to learn how cutting back on animal testing by using AI technology can save the pharmaceutical industry time and money.
Published: 2025 年 9 月 2 日
您是否已为 FDA 逐步淘汰单抗（mAbs）动物试验做好准备？
This webinar will explain how new approach methodologies (NAMs), including in silico tools and computational modeling, can be integrated into your drug development programs to align with the FDA Roadmap to phase out animal tests.
